TY - JOUR
T1 - Fetal exposure to high maternal thyroid hormone levels causes central resistance to thyroid hormone in adult humans and mice
AU - Srichomkwun, Panudda
AU - Anselmo, Joao
AU - Liao, Xiao Hui
AU - Hönes, G. Sebastian
AU - Moeller, Lars C.
AU - Alonso-Sampedro, Manuela
AU - Weiss, Roy E.
AU - Dumitrescu, Alexandra M.
AU - Refetoff, Samuel
N1 - Funding Information:
This work was supported by National Institutes of Health Grant R37DK15070 (to S.R.) and by Seymour J. Abrams and Rabbi Morris Esformes Thyroid Funds. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Diabetes and Digestive and Kidney Diseases or the National Institutes of Health.
Publisher Copyright:
Copyright © 2017 Endocrine Society.
PY - 2017/9/1
Y1 - 2017/9/1
N2 - Context: Fetuses exposed to the high thyroid hormone (TH) levels of motherswith resistance to thyroid hormone beta (RTH-b), due to mutations in the THRB gene, have low birth weight and suppressed TSH. Objective: Determine if such exposure to high TH levels in embryonic life has a long-term effect into adulthood. Design: Observations in humans with a parallel design on animals to obtain a preliminary information regarding mechanism. Setting: University research centers. Patients or other participants: Humans and mice with no RTH-b exposed during intrauterine life to high TH levels from mothers who were euthyroid due to RTH-b. Controls were humans and mice of the same genotype but born to fathers with RTH-b and mothers without RTH-b and thus, with normal serum TH levels. Interventions: TSH responses to stimulation with thyrotropin-releasing hormone (TRH) during adult life inhumans andmalemice before andafter treatment with triiodothyronine (T3).Wealsomeasured gene expression in anterior pituitaries, hypothalami, and cerebral cortices of mice. Results: Adult humans and mice without RTH-b, exposed to high maternal TH in utero, showed persistent central resistance to TH, as evidenced by reduced responses of serum TSH to TRH when treated with T3. In mice, anterior pituitary TSH-b and deiodinase 3 (D3) mRNAs, but not hypothalamic and cerebral cortex D3, were increased. Conclusions: Adult humans andmice without RTH-b exposed in utero to highmaternal TH levels have persistent central resistance to TH. This is likelymediated by the increased expression ofD3in the anterior pituitary, enhancing local T3 degradation.
AB - Context: Fetuses exposed to the high thyroid hormone (TH) levels of motherswith resistance to thyroid hormone beta (RTH-b), due to mutations in the THRB gene, have low birth weight and suppressed TSH. Objective: Determine if such exposure to high TH levels in embryonic life has a long-term effect into adulthood. Design: Observations in humans with a parallel design on animals to obtain a preliminary information regarding mechanism. Setting: University research centers. Patients or other participants: Humans and mice with no RTH-b exposed during intrauterine life to high TH levels from mothers who were euthyroid due to RTH-b. Controls were humans and mice of the same genotype but born to fathers with RTH-b and mothers without RTH-b and thus, with normal serum TH levels. Interventions: TSH responses to stimulation with thyrotropin-releasing hormone (TRH) during adult life inhumans andmalemice before andafter treatment with triiodothyronine (T3).Wealsomeasured gene expression in anterior pituitaries, hypothalami, and cerebral cortices of mice. Results: Adult humans and mice without RTH-b, exposed to high maternal TH in utero, showed persistent central resistance to TH, as evidenced by reduced responses of serum TSH to TRH when treated with T3. In mice, anterior pituitary TSH-b and deiodinase 3 (D3) mRNAs, but not hypothalamic and cerebral cortex D3, were increased. Conclusions: Adult humans andmice without RTH-b exposed in utero to highmaternal TH levels have persistent central resistance to TH. This is likelymediated by the increased expression ofD3in the anterior pituitary, enhancing local T3 degradation.
UR - http://www.scopus.com/inward/record.url?scp=85031006400&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85031006400&partnerID=8YFLogxK
U2 - 10.1210/jc.2017-00019
DO - 10.1210/jc.2017-00019
M3 - Article
C2 - 28586435
AN - SCOPUS:85031006400
VL - 102
SP - 3234
EP - 3240
JO - Journal of Clinical Endocrinology and Metabolism
JF - Journal of Clinical Endocrinology and Metabolism
SN - 0021-972X
IS - 9
ER -